EG

Edala Gopisai Phanindra

Active Director Director DIN 11074271
DIN 11074271 First appointment Apr 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Edala Gopisai Phanindra

Data last updated:

Edala Gopisai Phanindra is a Director at Elthium Healthcare Private Limited (since 2025). The company operates in Healthcare.

DIN 11074271
Primary Designation Director
Industry Healthcare
First Appointment 24 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Elthium Healthcare Private Limited U86903KA2025PTC201933
Director24 Apr 20252025Active

Board colleagues of Edala Gopisai Phanindra

NameDINCompanyDesignation
Padma Raja Bolla Ramesh10951280Elthium Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Elthium Healthcare Private Limited
Premium access

Shareholding and investment profile for Edala Gopisai Phanindra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Edala Gopisai Phanindra

Edala Gopisai Phanindra currently holds 1 directorship: Elthium Healthcare Private Limited (Director, since 24 Apr 2025).

Edala Gopisai Phanindra was first appointed on 24 Apr 2025 as Director at Elthium Healthcare Private Limited.

The current boards of Edala Gopisai Phanindra's companies include Padma Raja Bolla Ramesh (Elthium Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available